Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. Guidewire Rises On Improved Earnings, Above View
  2. Capitulation? Bitcoin ($BTC) Whale Holdings Drops to 29-Month Low
  3. Bitcoin (BTC) Market Analysis – 20 June 2023
  4. MoneyGram App Now Allows Buying and Selling of $BTC, $ETH, and $LTC
  5. New Survey Shows Nearly 50% Of Millennials And Gen Z Want Bitcoin, Cryptos In Their Retirement Fund